I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
| Title | I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth? |
| Publication Type | Journal Article |
| Year of Publication | 2018 |
| Authors | Verburg, F. A., Giovanella L., Iakovou I., Konijnenberg M. W., Langsteger W., Lassmann M., Mihailovic J., & Luster M. |
| Journal | Eur J Nucl Med Mol Imaging |
| Volume | 45 |
| Issue | 13 |
| Pagination | 2247-2249 |
| Date Published | 2018 12 |
| ISSN | 1619-7089 |
| Keywords | Hematologic Neoplasms, Humans, Incidence, Iodine Radioisotopes, Thyroid Neoplasms |
| Abstract | |
| DOI | 10.1007/s00259-018-4184-z |
| Alternate Journal | Eur J Nucl Med Mol Imaging |
| PubMed ID | 30298378 |
